共 9 条
[2]
*GEN, 2010, GEN PROV UPD AV ADV
[3]
HARRIS G, 2010, NY TIMES 0903
[4]
NAINGGOLAN L, FDA DOES U TURN MIDO
[5]
POLLACK A, 2010, NY TIMES 0917
[6]
Are surrogate markers adequate to assess cardiovascular disease drugs?
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1999, 282 (08)
:790-795
[7]
U.S. Government Accounting Office, 2009, NEW DRUG APPR FDA NE
[8]
*US FDA, 2010, FDA PROP WITHDR LOW
[9]
*US FDA, 2010, MID UPD SEPT 10

